Muhammad Siddiqui

Dr. Muhammad Siddiqui

Umm Al Qura University, Makkah, KSA

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Bioorganic Chemistry
Verified
Journal Article
Closed access
KAKhalid M. Attalah
Khalid M. Attalah
Ashraf N. AbdallaAshraf N. Abdalla
Ashraf N. Abdalla
MAMohammed Akhmad Aslam
Mohammed Akhmad Aslam
MSMuhammad Siddiqui
Muhammad Siddiqui
MAMohammed Abdelwahab Sayed Abourehab
Mohammed Abdelwahab Sayed Abourehab
AGAhmed Gouda
Ahmed Gouda


17 June 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MIMuhammad Shahid Iqbal
Muhammad Shahid Iqbal
FMFares M. S. Muthanna
Fares M. S. Muthanna
YKYaman Walid Kassab
Yaman Walid Kassab
MHMohamed Azmi Hassali
Mohamed Azmi Hassali
FAFahad I Alsaikhan
Fahad I Alsaikhan
MAMajid Ali
Majid Ali
The effect of anticoagulation control on overall Health-Related Quality of Life (HRQoL) in patients taking warfarin in Pakistan has not been explored yet. Therefore, this study aimed to evaluate HRQoL among warfarin patients in Pakistan. This cross-sectional study was conducted among patients on warfarin in Pakistan. By purposive sampling, data were collected using demographic data collection form and the World Health Organization Quality of Life: Brief Version (WHOQOL-BREF). The WHOQOL-BREF is comprised of four domains; physical, psychological, social relationships, and environment. Descriptive and inferential statistical analysis was done using SPSS version 22. Out of 295 warfarin patients, more females than males (<0.001) were observed (n = 184, 62.4%, and n = 111, 37.6% respectively). One hundred and eighteen (40.0%) patients were less than 30-years of age, whereas one hundred and seventy-seven (60.0%) patients were above 30-years of age. Mean scores for the physical (62.44±15.36), psychological (67.84±15.54), social (64.27±26.28) and environment domains (63.45±17.66) were observed. Patients had overall lower to moderate but satisfactory HRQoL scores in all four domains. Age, gender, employment status, education level, the indication of use and duration of warfarin therapy was associated with one or more domains of HRQoL among warfarin patients. The findings of this study would serve as a primary database for future studies. This study highlights how non-clinical factors could impact HRQoL in studied patients.

13 April 2018 in Metabolic Brain Disease
Verified
Journal Article
Closed access
PDF file
WAWaheeb D. M. Alharbi
Waheeb D. M. Alharbi
AAAisha Azmat
Aisha Azmat
MSMuhammad Siddiqui
Muhammad Siddiqui

4 July 2018 in Acta Pharmaceutica
Verified
Journal Article
Open access
PDF file
AGAhmed Gouda
Ahmed Gouda
AAAhmed H. Abdelazeem
Ahmed H. Abdelazeem
Ashraf N. AbdallaAshraf N. Abdalla
Ashraf N. Abdalla
MSMuhammad Siddiqui
Muhammad Siddiqui
Towards optimization of the pyrrolizine-5-carboxamide scaffold, a novel series of six derivatives ( 4a-c and 5a-c ) was prepared and evaluated for their anti-inflammatory, analgesic and anticancer activities. The ( EZ )-7-cyano-6-((4-hydroxybenzylidene)amino)- N -( p -tolyl)-2,3-dihydro-1 H -pyrrolizine-5-carboxamide ( 4b ) and ( EZ )-6-((4-chlorobenzylidene)-amino)-7-cyano- N -( p -tolyl)-2,3-dihydro-1 H -pyrrolizine-5-carboxamide ( 5b ) bearing the electron donating methyl group showed the highest anti-inflammatory activity while ( EZ )-6-((4-chlorobenzylidene)amino)-7-cyano- N -phenyl-2,3-dihydro-1 H -pyrrolizine-5-carboxamide ( 5a ) was the most active analgesic agent. Cytotoxicity of the new compounds was evaluated against the MCF-7, A2780 and HT29 cancer cell lines using the MTT assay. Compounds 4b and 5b displayed high anticancer activity with IC 50 in the range of 0.30–0.92 μmol L −1 against the three cell lines, while compound ( EZ )- N -(4-chlorophenyl)-7-cyano-6-((4-hydroxybenzylidene)-amino)-2,3-dihydro-1 H -pyrrolizine-5-carboxamide ( 4c ) was the most active against MCF-7 cells ( IC 50 = 0.08 μmol L −1 ). Both the anti-inflammatory and anticancer activities of the new compounds were dependent on the type of substituent on the phenyl rings. Substituents with opposite electronic effects on the two phenyl rings are preferable for high cytotoxicity against the MCF-7 and A2780 cells. COX inhibition was suggested as the molecular mechanism of the anti-inflammatory activity of the new compounds while no clear relationship could be observed between COX inhibition and anticancer activity. Compound 5b , the most active against the three cell lines, induced dose-dependent early apoptosis with 0.1–0.2 % necrosis in MCF-7 cells. New compounds showed promising drug-likeness scores while the docking study revealed high binding affinity to COX-2. Taken together, this study highlighted the significant impact of the substituents on the anti-inflammatory and anticancer activity of pyrrolizine-5-carboxamides, which could help in further optimization to discover good leads for the treatment of cancer and inflammation.

15 June 2017 in International Journal of Pharmacology
Verified
Journal Article
Closed access
MMMohammed Mukhtar
Mohammed Mukhtar
WAWaleed Hassan Almalki
Waleed Hassan Almalki
AAAisha Azmat
Aisha Azmat
MAMohammad Raafat Abd
Mohammad Raafat Abd
MSMuhammad Siddiqui
Muhammad Siddiqui